to reduce excess body weight and maintain weight reduction long term in: o adults and pediatric patients aged 12 years and older with obesity
PMID 24032598
Cost Plus Drugs near-term formulary expansion opportunities sit primarily in the small-molecule generic space, where the revenue cliff is steeper and faster
Red flags include vendors offering GLP-1 medications without requiring a prescription, claiming FDA approval for compounded drugs, or operating from unregistered facilities
Nakamura JL, Phong C, Pinarbasi E, Kogan SC, Vandenberg S, Horvai AE, et al
Int J Gynaecol Obstet 147:5964 Sharkwy I, Sharaf DM (2019) LC plus metformin in clomiphene-resistant obese PCOS